Lipopeptide-based pan-CoV fusion inhibitors potently inhibit HIV-1 infection.

ABSTRACT:

SUBMITTER: Lan Q 

PROVIDER: S-EPMC8133820 | biostudies-literature | 2021 May

REPOSITORIES: biostudies-literature